Peroxisomal Ocular Diseases

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 23 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Article Summary

Peroxisomal ocular diseases are eye problems that happen because tiny cleaning-and-building stations inside our cells—called peroxisomes—do not work properly. Peroxisomes help the body break down very-long and unusual fatty acids, control harmful oxygen by-products, and make key building blocks for cell membranes called plasmalogens. When peroxisomes fail, certain fats build up and helpful lipids are missing. The eye—especially the retina (the film at the back...

Key Takeaways

  • This article explains Pathophysiology in simple medical language.
  • This article explains Types in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Common symptoms in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Sudden vision loss, severe eye pain, new flashes, or many new floaters.
  • Eye symptoms after injury or chemical exposure.
  • Rapidly worsening redness, swelling, or vision changes.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Peroxisomal ocular diseases are eye problems that happen because tiny cleaning-and-building stations inside our cells—called peroxisomes—do not work properly. Peroxisomes help the body break down very-long and unusual fatty acids, control harmful oxygen by-products, and make key building blocks for cell membranes called plasmalogens. When peroxisomes fail, certain fats build up and helpful lipids are missing. The eye—especially the retina (the film at the back of the eye that senses light), the optic nerve (the cable to the brain), the lens, and the cornea—is very sensitive to those changes. As a result, people can develop pigmentary retinopathy (a “retinitis pigmentosa–like” degeneration), cataract, corneal clouding, glaucoma, optic atrophy, nystagmus, and progressive vision loss. These ocular issues are well described in classic peroxisomal conditions such as Zellweger spectrum disorder, Adult/Infantile Refsum disease, Rhizomelic Chondrodysplasia Punctata (RCDP), and X-linked adrenoleukodystrophy (X-ALD). PMCEyeWikiNCBI+1

Peroxisomal ocular diseases are eye problems that happen because tiny cell “recycling centers” called peroxisomes don’t work properly. When peroxisomes fail, certain fats build up (or key protective fats are too low), and the retina, lens, cornea, and optic nerve can be damaged over time. The result can include night blindness, cataracts, corneal clouding, nystagmus (shaky eyes), and vision loss. Peroxisomes help make DHA (an omega-3 crucial for the retina) and plasmalogens (membrane lipids important for lens clarity and nerve cells), and they break down very-long-chain and branched-chain fatty acids; disruptions in these pathways explain many eye findings. ResearchGatefightingblindness.org

Pathophysiology

Think of the retina and optic nerve as high-performance “electric tissues” packed with fats that need to be exactly the right kind and length. Peroxisomes:

  • Break down very-long-chain fatty acids (VLCFAs) and certain branched-chain fatty acids (like phytanic acid). If this fails, toxic lipids build up in retinal cells and in myelin (the insulation of optic pathways), injuring vision. PMCbiomolther.org

  • Help make plasmalogens, special membrane lipids that keep photoreceptors and lens fibers healthy and flexible; when plasmalogens are low (for example in RCDP), cataracts and retinal dysfunction are common. ScienceDirect

  • Contribute to long-chain polyunsaturated fatty acids (like DHA) homeostasis via peroxisomal β-oxidation steps, which supports photoreceptor outer-segment renewal. Problems here disturb photoreceptor structure and function. PMCPNAS

Types

You can group peroxisomal ocular diseases in two overlapping ways—by the underlying disorder and by the main eye structures affected.

A) By underlying peroxisomal disorder

  1. Peroxisome Biogenesis Disorders (PBDs) – Zellweger Spectrum Disorder (ZSD)
    Due to pathogenic variants in PEX genes (peroxins). The spectrum runs from severe neonatal disease to milder childhood/adult forms. Eye findings include cataract, corneal clouding, glaucoma, pigmentary retinopathy, macular atrophy, optic atrophy, and nystagmus. NCBITaylor & Francis OnlineOrpha.net

  2. Rhizomelic Chondrodysplasia Punctata (RCDP)
    Classically from PEX7 (type 1) or single-enzyme defects in plasmalogen synthesis (GNPAT, AGPS). Eye hallmark: early bilateral cataracts; many patients also have retinal dysfunction and nystagmus. NCBI+1

  3. Adult Refsum Disease (ARD) / Infantile Refsum Disease (IRD)
    ARD commonly due to PHYH variants (phytanoyl-CoA hydroxylase) or PEX7; IRD belongs to the ZSD spectrum. The typical eye picture is retinitis pigmentosa–like degeneration with night blindness, field constriction, and often cataract. NCBIGenetic Eye Diseases Database

  4. X-Linked Adrenoleukodystrophy (X-ALD)
    Due to ABCD1 variants (a peroxisomal membrane transporter for VLCFAs). Visual loss and optic atrophy occur as part of the demyelinating leukodystrophy; MRI often shows posterior white-matter disease. PubMedPMC

  5. Single-enzyme β-oxidation defects
    Examples include ACOX1 deficiency (acyl-CoA oxidase), HSD17B4 (D-bifunctional protein) defects; both may present with severe retinal/optic involvement within broader neurologic disease. (Mechanism: failed peroxisomal β-oxidation → toxic lipid buildup.) PMC

  6. Recently described/rare peroxisomal lipid disorders
    ACBD5 deficiency impairs VLCFA handling and has been linked to retinal disease in preclinical/clinical literature, highlighting peroxisomal involvement in retinal health. MDPI

B) By main eye structures involved

  • Retina: rod–cone degeneration with bone-spicule pigmentation, attenuated vessels, pale optic disc; ERG shows rod then cone dysfunction; can include macular atrophy. Typical in ARD/IRD, ZSD. Genetic Eye Diseases DatabaseTaylor & Francis Online

  • Optic nerve & visual pathways: optic atrophy and visual field loss, especially in X-ALD because of posterior white-matter demyelination. PubMed

  • Lens: early cataracts, especially in RCDP and sometimes ZSD/ARD. NCBIEyeWiki

  • Cornea/Anterior segment: corneal clouding/opacification and sometimes glaucoma in severe ZSD. Orpha.net

Causes

Below are “causes” framed as the specific gene or pathway problem that triggers eye disease, plus the plain-language mechanism. (Many of these are rare; the list is intentionally comprehensive.)

  1. PEX1 variants (ZSD) – cannot assemble normal peroxisomes; VLCFAs and bile acid intermediates build up; plasmalogens low → retinal degeneration, cataract, optic atrophy. BioMed Central

  2. PEX6 variants (ZSD/Heimler) – similar peroxisome-assembly failure → milder to severe ocular involvement. BioMed Central

  3. PEX10 / PEX12 / PEX26 variants (ZSD) – blocks protein import into peroxisomes → toxic lipid accumulation harms retina and lens. BioMed Central

  4. PEX2 / PEX3 / PEX5 / PEX13 / PEX14 variants (ZSD) – other peroxisome biogenesis steps fail; the shared result is retinal and optic nerve damage. BioMed Central

  5. PEX7 variants (RCDP type 1) – loss of PTS2 import → low plasmalogens; lens fibers stiffen and scatter light → early cataracts; photoreceptors also suffer. NCBI

  6. GNPAT variants (RCDP type 2) – first step of plasmalogen synthesis impaired → early cataracts/retinal dysfunction. ScienceDirect

  7. AGPS variants (RCDP type 3) – block the ether-lipid pathway further downstream → cataract and retinal changes. ScienceDirect

  8. PHYH variants (Adult Refsum disease) – cannot break down phytanic acid; it accumulates in retina → night blindness, field loss, cataract. NCBI

  9. (PEX7-related) Refsum disease – same final pathway (phytanic acid overload) via faulty peroxisomal import; similar eye impact. NCBI

  10. ABCD1 variants (X-ALD) – VLCFAs cannot enter peroxisomes for β-oxidation; white-matter demyelination and optic atrophy; visual cortex involvement. NCBI

  11. ACOX1 deficiency – first step of peroxisomal β-oxidation fails; VLCFAs rise; severe neuro-ophthalmic disease early in life. gimjournal.org

  12. HSD17B4 (D-bifunctional protein) deficiency – middle steps of peroxisomal β-oxidation fail; retinal/optic dysfunction plus high bile acid intermediates. PMC

  13. AMACR deficiency – bile-acid side-chain processing abnormal; buildup of specific C27 intermediates (THCA/DHCA) can accompany neurological and visual issues. ScienceDirect

  14. FAR1 deficiency – impaired fatty acyl-CoA reductase impacts plasmalogen balance; may contribute to lens/retina pathology. (Mechanism: defective ether-lipid synthesis.) ScienceDirect

  15. ACBD5 deficiency – defective peroxisome–ER tethering/very-long-chain acyl-CoA handling; linked to retinal disease biology. MDPI

  16. Pipecolic acid metabolism defects (PIPOX) or biogenesis-related hyperpipecolic acid in ZSD – biomarker of peroxisomal failure; associated with ocular involvement within the multisystem picture. PubMedMayo Clinic Laboratories

  17. Bile-acid peroxisomal oxidation defects (accumulation of DHCA/THCA) – toxic intermediates reflect β-oxidation failure; often coexist with retinal changes in ZSD. PMC

  18. Docosahexaenoic acid (DHA) deficiency at the peroxisomal step – impairs photoreceptor outer-segment renewal; function declines. PMC

  19. General oxidative stress from peroxisomal dysfunction – excess reactive oxygen species and weak antioxidant handling damage lenses and photoreceptors over time. (Mechanistic concept in peroxisome biology reviews.) PMC

  20. Compound or mixed peroxisomal defects (e.g., combined plasmalogen deficiency + VLCFA accumulation as in parts of the ZSD spectrum) – add-on effects that worsen retinal and lens disease. BioMed Central

Common symptoms

  1. Night blindness – trouble seeing in dim light, typical of rod damage in a retinitis pigmentosa–like process (common in Refsum disease and ZSD). Genetic Eye Diseases Database

  2. Peripheral field loss – “tunnel vision,” starting at the edges and moving inward as retinal degeneration progresses. Genetic Eye Diseases Database

  3. Glare and halos – especially when cataracts scatter light in RCDP/ZSD. NCBI

  4. Blurred central vision – from macular involvement or cataract; reading and face recognition get harder. Taylor & Francis Online

  5. Color vision changes – colors look washed out or confusing when cones and macula are affected. (Seen in cone-rod involvement.) NCBI

  6. Photophobia – bright light hurts or overwhelms vision when the retina is stressed. NCBI

  7. Nystagmus – eyes “wiggle” because the brain struggles to stabilize a weak retinal signal; common in infant-onset disease like ZSD/RCDP. Orpha.net

  8. Poor fixation in infancy – babies don’t hold gaze well or follow faces because of early retinal dysfunction. Orpha.net

  9. Frequent bumping into objects – a simple sign of field loss. Genetic Eye Diseases Database

  10. Reduced contrast sensitivity – low-contrast text or steps become hard to see. (Typical in retinal dystrophies.) NCBI

  11. Headaches/eye tendon. সহজ বাংলা: মাংসপেশি/টেনডনে টান।" data-rx-term="strain" data-rx-definition="A strain is injury to a muscle or tendon. সহজ বাংলা: মাংসপেশি/টেনডনে টান।">strain – from trying to see through cataract or narrowed fields. NCBI

  12. Intermittent double vision or misalignment – strabismus can appear when vision is poor in one eye or central processing is disrupted (reported in RCDP and ALD). NCBIGenetic Eye Diseases Database

  13. Loss of sharpness (acuity) – gradual or sometimes stepwise, depending on the mix of cataract, macular disease, and optic atrophy. Taylor & Francis Online

  14. Pale optic disc changes noticed by clinicians – signals optic nerve atrophy, especially in ALD/ZSD. PubMed

  15. Glaucoma symptoms (late) – halos, pain, or none at all; raised pressure is described in severe ZSD. Orpha.net

Diagnostic tests

A) Physical Exam (bedside observations & clinician-performed checks)

  1. External inspection & ocular alignment
    The doctor looks for nystagmus, strabismus, ptosis, and facial clues of syndromic disease. These quick clues point toward early retinal dysfunction (nystagmus) or central pathway disease (ALD). Orpha.net

  2. Pupil reflex testing (swinging-flashlight test)
    Assesses afferent pathway function. An asymmetrical or sluggish response suggests optic nerve/retinal dysfunction that can occur in ALD or advanced retinopathy. (Core neuro-ophthalmic exam principle.)

  3. Slit-lamp examination of the anterior segment
    Directly shows cataracts (often early in RCDP; variable in ZSD/ARD) and corneal clouding in severe ZSD. NCBIOrpha.net

  4. Intraocular pressure (IOP) measurement
    Elevated IOP supports glaucoma, reported in severe ZSD. Treatable IOP elevation can protect the nerve if caught. Orpha.net

B) Manual tests (simple functional tests done in clinic)

  1. Age-appropriate visual acuity testing
    From Teller cards in infants to Snellen charts in adults. Declining acuity tracks macular/optic disease.

  2. Confrontation visual fields
    A quick screen for peripheral vision loss; tunnel fields commonly accompany peroxisomal retinopathies.

  3. Amsler grid
    At-home or in-clinic grid to spot central distortions from macular involvement (useful in milder forms).

  4. Color vision (Ishihara or Hardy–Rand–Rittler)
    Detects cone and macular dysfunction, often affected as rod-cone disease advances. (Standard retinal dystrophy work-up.) NCBI

C) Laboratory & Pathological tests (biochemical and genetic)

  1. Plasma VLCFAs and/or C26:0-lysophosphatidylcholine (C26:0-LPC)
    Cornerstone screening for peroxisomal β-oxidation defects. C26:0-LPC is now widely used for X-ALD and other peroxisomal disorders in blood spots and plasma. NCBIMayo Clinic LaboratoriesJAMA Network

  2. Phytanic acid and pristanic acid (plasma)
    These rise in Refsum disease and some ZSDs; reducing phytanic acid can even improve retinal function in ARD. NCBIPMC

  3. Erythrocyte plasmalogens
    Low plasmalogens support RCDP (and sometimes ZSD) because peroxisomal ether-lipid synthesis is impaired. ScienceDirect

  4. Bile-acid intermediates (THCA/DHCA) in plasma/urine
    Elevated C27 bile-acid intermediates indicate peroxisomal β-oxidation failure and are typical in ZSD and D-bifunctional protein deficiency. PMCjlr.org

  5. Pipecolic acid (plasma/urine)
    Often elevated in ZSD and helpful to separate biogenesis defects from single-enzyme defects; note that levels can be age-dependent. Mayo Clinic LaboratoriesPubMed

  6. Fibroblast studies (peroxisomal enzyme assays and peroxisome immunofluorescence)
    Cultured-cell testing confirms β-oxidation/plasmalogen defects and shows absent/mislocalized peroxisomal proteins in PBDs. (Laboratory practice guidance.) gimjournal.org

  7. Targeted or panel genetic testing
    Confirms the diagnosis and guides counseling: PEX gene panels for ZSD, ABCD1 for X-ALD, PHYH/PEX7 for Refsum, GNPAT/AGPS for RCDP, ACOX1/HSD17B4 for single-enzyme β-oxidation defects. NCBI+1

D) Electrodiagnostic tests

  1. Full-field Electroretinography (ERG)
    Objective measure of retinal function; shows early rod dysfunction in RP-like disease and tracks progression—even when the fundus still looks mild. PubMed

  2. Visual Evoked Potentials (VEP)
    Measures the brain’s electrical response to visual stimuli; picks up delayed/low signals from optic nerve or white-matter disease (high yield in ALD). (Neuro-ophthalmic standard.)

  3. Electro-oculography (EOG)
    Assesses retinal pigment epithelium/photoreceptor interaction. Abnormal Arden ratio can support generalized retinal dystrophy. (Used alongside ERG.) NCBI

E) Imaging tests

  1. Optical Coherence Tomography (OCT) and Fundus Autofluorescence (FAF)
    OCT shows thinning and outer-segment loss; FAF maps metabolic stress in the RPE. In X-ALD, structural retinal changes can be subtle or appear after neuro disease evolves. ScienceDirect

  2. MRI of brain and visual pathways
    Essential when ALD or severe ZSD is suspected. Posterior (occipital-parietal) white-matter demyelination supports ALD and explains rapid visual decline. PMC

Non-pharmacological treatments

  1. Low-vision rehabilitation — structured training and devices to use remaining vision better; improves independence and quality of life. Mechanism: skills, magnification, contrast, lighting strategies. NCBI

  2. Orientation & mobility (O&M) training — safe navigation indoors/outdoors using canes, landmarks, and auditory cues. Purpose: safety and confidence.

  3. Tinted/filtered lenses (UV/blue-block) — reduce glare/phototoxic stress; support comfort and possibly protect fragile photoreceptors. NCBI

  4. High-contrast, task lighting, and glare control at home — improves reading and reduces falls; mechanism: better signal-to-noise for low vision.

  5. Magnifiers and electronic aids (CCTV, apps, screen readers) — enlarge fonts and boost contrast; immediate function gains.

  6. School IEP/early-intervention services — for children with ZSD/RCDP: large-print materials, seating, assistive tech; prevents developmental visual deprivation.

  7. Scleral contact lenses — vault the cornea, bathe it in saline, and smooth optical surface, helping keratopathy and irregular optics. Purpose: comfort and clearer vision. MedlinePlus

  8. Lubrication routine + environmental tweaks (humidifiers, blink breaks) — stabilizes tear film to reduce erosions and pain.

  9. Lid hygiene & warm compresses — improves meibomian gland oil quality; better tear stability.

  10. Amblyopia prevention (timely refractive correction; patching in select cases) — ensures the brain gets a clear image during critical periods.

  11. Prism or occlusion for diplopia — eases symptoms of ocular misalignment.

  12. Nutritional counseling for Adult Refsum disease (low phytanic acid plan) — cornerstone therapy; avoids ruminant fats/dairy/some fish; spread carbs through the day; no fasting. Mechanism: lower phytanic acid burden, which may slow eye/nerve damage. NCBIDARE

  13. Emergency avoidance of fasting/rapid weight loss in Refsum — prevents sudden phytanic acid release from fat stores. NCBI

  14. Cardio-metabolic lifestyle care (sleep, exercise adapted to abilities) — maintains overall function and reduces secondary eye tendon. সহজ বাংলা: মাংসপেশি/টেনডনে টান।" data-rx-term="strain" data-rx-definition="A strain is injury to a muscle or tendon. সহজ বাংলা: মাংসপেশি/টেনডনে টান।">strain.

  15. Sun protection (hats, wrap-around sunglasses) — lowers UV load to sensitive retina/cornea.

  16. Falls-prevention home setup (contrast tape on steps, decluttering) — protects people with field loss.

  17. Hearing aids or speech therapy — practical if hearing is affected (common in Refsum/ZSD), improving communication and safety. NCBI

  18. Counseling/peer support — coping skills and adherence support for lifelong conditions.

  19. Genetic counseling — helps families understand inheritance and plan future pregnancies. NCBI

  20. Regular scheduled eye/medical follow-ups — early detection of cataract/CME/glaucoma changes improves outcomes.

Drug treatments

Safety first: doses below are typical adult regimens; pediatric doses and individual plans differ. Always follow your clinician’s prescription.

  1. Cholic acid (oral; e.g., CHOLBAM®) — For ZSD with bile-acid abnormalities to reduce toxic C27 intermediates and improve growth/liver chemistries. Dose: per label (weight-based, often 10–15 mg/kg/day total). Purpose: restore bile-acid balance and fat absorption; Mechanism: provides primary bile acid → feedback suppression of toxic intermediates. Side effects: diarrhea, liver enzyme changes; specialist monitoring required. BioMed CentralPMC

  2. Topical carbonic anhydrase inhibitors (CAIs): dorzolamide 2% or brinzolamide 1% (eye drops) — for cystoid macular edema in RP-like retinopathy. Dose: 1 drop TID. Purpose: reduce macular fluid; Mechanism: lowers fluid transport into retina. Side effects: stinging, bitter taste; rarely corneal edema. PMC

  3. Oral acetazolamide 250 mg (BID–TID) — alternative for RP-related CME. Purpose/mechanism: systemic CAI drying effect. Side effects: tingling, fatigue, kidney stones; avoid in sulfa allergy. PMC

  4. Lubricating eye drops (carboxymethylcellulose, hyaluronate) — frequent use (QID or more) for keratopathy/dry eye. Mechanism: tear film replacement; Side effects: minimal (preservative sensitivity possible).

  5. Topical cyclosporine 0.05% (BID) or lifitegrast 5% (BID) — for inflammatory dry eye/surface disease. Mechanism: T-cell modulation; Side effects: burning/dysgeusia. AAO Journal

  6. Short-course topical corticosteroid (e.g., loteprednol 0.5% QID, tapered) — for episodic keratitis/uveitis under supervision. Mechanism: infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation, pain, or swelling. সহজ বাংলা: প্রদাহ/ফোলা/ব্যথা কমায়।" data-rx-term="anti-inflammatory" data-rx-definition="Anti-inflammatory means reducing inflammation, pain, or swelling. সহজ বাংলা: প্রদাহ/ফোলা/ব্যথা কমায়।">anti-inflammatory; Side effects: IOP rise, cataract with prolonged use; needs monitoring.

  7. Antiglaucoma drops (timolol 0.5% BID, or prostaglandin analogs like latanoprost 0.005% QHS when infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation is controlled) — bridge or adjunct around glaucoma surgery when needed. Mechanism: lower intraocular pressure; Side effects: local irritation; prostaglandins can worsen inflammation—ophthalmologist guidance required.

  8. Antibiotic drops (e.g., moxifloxacin 0.5%) for corneal ulcers/erosions when infected. Dose: per protocol; Side effects: irritation.

  9. Hypertonic saline 5% drops/ointment — for recurrent corneal epithelial edema/erosions; Mechanism: draws out fluid.

  10. Systemic therapies for Refsum (adjuncts) — plasmapheresis (procedure) is used acutely when phytanic acid is dangerously high (not a “drug” but crucial to know). Docosahexaenoic acid (DHA) and cholic acid combinations have been explored in ARD in selected reports, but diet remains core therapy. NCBIMedscape

Dietary molecular supplements

Supplements are adjuncts — not cures. Discuss interactions (e.g., blood-thinners) with your clinician.

  1. DHA (docosahexaenoic acid) 200–1,000 mg/day — supports photoreceptor membranes. Mechanism: replaces key omega-3 in retinal discs; theoretical benefit when peroxisomes undersupply DHA. ResearchGate

  2. Lutein 10 mg + Zeaxanthin 2 mg/day — boosts macular pigment; filters blue light and quenches free radicals; some RP studies explored carotenoids. PMC

  3. Vitamin E 200–400 IU/day — antioxidant for membrane lipids; caution in anticoagulation. (Mechanistic support in oxidative stress.) fightingblindness.org

  4. Vitamin C 500 mg/day — aqueous antioxidant recycling vitamin E; supports collagen in cornea.

  5. Zinc 25–40 mg/day (short courses) — cofactor in retinal enzymes; avoid long-term excess (copper deficiency risk).

  6. N-acetylcysteine (NAC) 600 mg BID–TID — replenishes glutathione; early RP studies suggest potential functional benefit in some patients. Medlink

  7. Coenzyme Q10 (ubiquinone) 100–300 mg/day — mitochondrial antioxidant; small studies show neuro-ocular support potential. Nature

  8. Alpha-lipoic acid 300 mg/day — redox cycling antioxidant; may reduce oxidative stress in neural tissues. Taylor & Francis Online

  9. Taurine 500–1,000 mg/day — abundant in retina; osmoprotection/antioxidant roles (supportive theory).

  10. Magnesium 200–400 mg/day — neuromuscular support; may ease vasospasm-like visual symptoms in some settings.

Important Refsum note: DHA from fish oil can be problematic if it carries phytanic acid; use purified DHA sources and work with a metabolic dietitian. Diet in ARD avoids ruminant fats/dairy and some fish; it also avoids fasting. NCBI

Regenerative / immune-support” therapies

  1. Elivaldogene autotemcel (SKYSONA®) — a gene therapy for early cerebral X-ALD, not an eye drug but relevant to the peroxisomal family. It’s a single autologous lentiviral infusion after myeloablation; recent label changes add lifelong monitoring for hematologic malignancy. Purpose: stabilize neurologic decline; Mechanism: adds functional ABCD1 to hematopoietic stem cells. (Ocular benefit is not established.) Wikipediafightingblindness.org

  2. Hematopoietic stem cell transplantation (HSCT) — standard for early CALD (again systemic). Mechanism: donor or gene-corrected cells repopulate microglia; eye outcomes unclear. AAO

  3. Autologous serum tears (ASEDs) — biologic drops prepared from the patient’s blood for severe ocular surface disease. Typical use: 20%–100% serum, QID to hourly (specialist protocol). Mechanism: growth factors and vitamins mimic natural tears. Evidence: can help severe dry eye and persistent epithelial defects, though RCT certainty is limited. AAOAAO Journal

  4. Platelet-rich plasma (PRP) eye drops — growth-factor-rich drops; emerging evidence for dry eye/epithelial healing. Dosing: center-specific (e.g., QID). Mechanism: platelet factors support regeneration. PMCScienceDirect

  5. Plasmalogen precursors (e.g., PPI-1011) — investigational oral therapy aiming to raise plasmalogens in RCDP and related states; early human PK/safety data show serum plasmalogen increases, but clinical efficacy for vision is unproven. Do not use outside trials. PMC

  6. Unregulated “stem-cell” eye injections — avoid them. The AAO and FDA warn of severe complications, including blindness, from unapproved clinic injections. Seek only IRB-approved, regulated trials. AAO+1

Surgeries

  1. Pediatric cataract extraction (with/without IOL) — to clear the visual axis early in infants/children (e.g., RCDP) and prevent amblyopia. Procedure: lens removal via small incisions, often with posterior capsulotomy and anterior vitrectomy in very young children. Why: cataracts block images during critical visual development. PMCNational Eye Institute

  2. Posterior capsulotomy (YAG laser) after cataract surgery — opens secondary capsular haze to restore clarity. Why: improves vision when posterior capsule opacifies. World Health Organization

  3. Glaucoma surgery (goniotomy/trabeculotomy in infants; trabeculectomy/drainage devices later) — Why: protect optic nerve when pressure is uncontrolled by drops. National Eye Institute

  4. Keratoplasty (corneal transplant) or amniotic membrane graft — for severe keratopathy/scar that blocks vision or fails medical therapy. Why: restore clarity and epithelium. MedlinePlus

  5. Strabismus surgery — to align eyes for better function and appearance when large, stable misalignment persists despite glasses/therapy. Why: expand binocular field and reduce diplopia.

Prevention strategies

  1. Genetic counseling for families with a known diagnosis (carrier testing, prenatal/preimplantation options). NCBI

  2. Newborn/early screening in at-risk families (biochemical/genetic) to begin supportive care sooner. NCBI

  3. Refsum-specific diet for life (low phytanic acid) and no fasting/rapid dieting; coordinate with a metabolic dietitian. NCBI

  4. Sun/UV protection (wrap-around sunglasses, hats) to limit phototoxic stress.

  5. Prompt treatment of eye surface disease (lubrication/lid care) to prevent recurrent erosions and scarring.

  6. Regular eye checks (OCT/FAF/ERG when indicated) to catch macular edema, cataract progression, and pressure changes early. PLOS+1

  7. Vaccinations and infection prevention (systemic health protects eyes indirectly).

  8. Safe home setup (lighting, contrast tape, remove tripping hazards) to prevent injury in field loss.

  9. Education supports (IEP/assistive tech) to prevent developmental visual deprivation in children.

  10. Avoid unproven “stem-cell” clinics offering eye injections. AAO

When to see a doctor

  • Right away (urgent): sudden drops in vision, new eye pain/redness, halos with headache/nausea (possible angle-closure), signs of corneal infection (severe light sensitivity with discharge), or drastic visual field loss.

  • Soon (within weeks): new floaters/flashes, worsening glare or cloudiness, increasing light sensitivity, a child who isn’t fixing and following, or a new eye turn.

  • Routine (3–12 months, individualized): known peroxisomal disorder with stable vision — schedule periodic OCT/pressure checks, and metabolic follow-up to keep diet/labs optimized. PLOS

What to eat  and what to avoid

One size does not fit all. Adult Refsum disease has specific exclusions. Work with your metabolic dietitian and ophthalmologist.

Often helpful (general eye-healthy patterns; adjust for ARD):

  1. Leafy greens (spinach, kale) — lutein/zeaxanthin.

  2. Colored veggies & citrus — vitamin C and carotenoids.

  3. Nuts/seeds (in moderation) — vitamin E and minerals (avoid walnuts if advised in ARD; see below).

  4. Legumes & whole grains — steady carbs to avoid fasting dips in ARD. DARE

  5. Lean poultry/eggs — protein without ruminant fats.

  6. Plant oils (canola, olive, flax) — sources of essential fatty acids without phytanic acid. DARE

  7. Purified algal-based DHA if recommended (not fish-fat). ResearchGate

  8. Plenty of water — supports ocular surface.

  9. Fortified low-phytanic alternatives (dietitian-approved). DARE

  10. Regular meals/snacks — no fasting in ARD. NCBI

Often avoid/limit (especially in Adult Refsum disease):

  1. Ruminant meats (beef, lamb, goat, mutton, venison).

  2. Dairy fats (butter, cream, full-fat milk, full-fat yogurt, ice cream).

  3. Baked goods with animal fats (read labels).

  4. Certain fish high in phytanic acid (e.g., cod, tuna, haddock); use dietitian lists.

  5. Offal (liver/kidney/tongue from ruminants).

  6. Added fish oils unless verified phytanic-free.

  7. Walnuts (listed among items to avoid in some ARD guides).

  8. Crash diets/ketogenic experiments (risk of phytanic acid release).

  9. Excess caffeine (some ARD guides advise moderation).

  10. Highly processed trans-fat snacks (poor for general vascular/ocular health). NCBICleveland ClinicDARE

Frequently asked questions

1) Is there a cure for peroxisomal ocular diseases?
Not yet. Treatment focuses on supporting vision, treating complications (like cataracts or macular edema), and controlling the metabolic disease (e.g., diet in Refsum; cholic acid in some ZSD patients). NCBIBioMed Central

2) Can diet really help my eyes in Refsum disease?
Yes. A low-phytanic-acid diet is the mainstay and may slow vision/hearing loss while clearly improving nerve/skin symptoms; avoid fasting. NCBI

3) What about DHA supplements?
DHA is a core retinal fatty acid; purified DHA (e.g., algal) may be discussed, but benefits vary, and fish-oil sources can carry phytanic acid (a problem in ARD). Decide with your team. ResearchGate

4) Are there eye drops for the “RP-like” changes?
Drops can’t reverse RP, but carbonic anhydrase inhibitors (dorzolamide/brinzolamide; sometimes oral acetazolamide) can improve cystoid macular edema in some patients. PMC

5) Should I take high-dose vitamin A like older RP advice?
No self-dosing. Evidence is mixed and toxicity is real; your doctor will advise case-by-case. Standard modern care favors safety and individualized plans. PMC

6) When do children need cataract surgery?
If cataracts block vision in infancy/early childhood (common in RCDP), surgery is often done early to allow normal visual development. PMC

7) What is cholic acid therapy and does it help the eyes?
Cholic acid treats liver/bile-acid issues in ZSD; it improves labs and growth but hasn’t been proven to directly fix retinal degeneration. It supports overall health that indirectly benefits vision care. BioMed Central

8) Are “stem-cell eye injections” safe?
Avoid unapproved clinics. The AAO/FDA report serious harms (including blindness). Consider only regulated clinical trials. AAO

9) What tests are most helpful to track my retina?
OCT (for macula/CME) and FAF (for degeneration patterns); ERG and VEP provide objective function when needed. PLOS+1

10) Can glasses or contacts help much?
Yes—correcting refractive error, using tints, and in some cases scleral lenses can noticeably improve day-to-day function even if they don’t change the underlying disease. MedlinePlus

11) Will my children be affected?
These conditions are genetic (often autosomal recessive). Genetic counseling explains carrier risks and testing options. NCBI

12) Is there a role for plasmapheresis?
In Refsum disease, yes—plasmapheresis or lipid apheresis is used for acute severe situations to rapidly lower phytanic acid. NCBI

13) What about PRP or serum eye drops?
For severe ocular surface disease, ASEDs or PRP can help healing and comfort in selected patients; evidence is supportive but still evolving. AAOPMC

14) Are there clinical trials I should watch?
Yes: plasmalogen precursors (e.g., PPI-1011) for RCDP are under study; participation is through formal trials only. ClinicalTrials

15) What’s the best “first step” after diagnosis?
Build a team: metabolic specialist + ophthalmologist (retina + pediatric if applicable) + low-vision rehab + genetic counselor + dietitian. Start regular follow-ups and safety upgrades at home/school.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 21, 2025.

PDF Document For This Disease Conditions

  1. Eye Diseases [rxharun.com]
  2. lucentis-epar-product-information-Eye Diseases [rxharun.com]
  3. jesc110 – Eye Diseases [rxharun.com]
  4. 9789240082458-eng [Eye Diseases (rxharun.com)]
  5. d1e1894daab433a1-9ed1066742d1-p67-Watson-et-al-v3 [Eye Diseases (rxharun.com)]
  6. PIIS0161642024000125 [Eye Diseases (rxharun.com)]
  7. OCT_in_Retinal_Diseases_Cozzi_EN [Eye Diseases (rxharun.com)]
  8. Eye76. Corneal Disorders [Eye Diseases (rxharun.com)]
  9. N.R. Galloway [Eye Diseases (rxharun.com)]
  10. OM – Definition & Classification [Eye Diseases (rxharun.com)]
  11. wcms_892937 [Eye Diseases (rxharun.com)]
  12. Diabetes1 [Eye Diseases (rxharun.com)]
  13. specific_eye_conditions [Eye Diseases (rxharun.com)]
  14. CEHJ95_Ocular-Surface-Disorders-1 [Eye Diseases (rxharun.com)]
  15. 17677-68019-2-PB [Eye Diseases (rxharun.com)]
  16. conditions [Eye Diseases (rxharun.com)]
  17. primary-care-approach-to-eye-conditions [Eye Diseases (rxharun.com)]
  18. Symptoms-Related-to-Eye-Diseases-and-Conditions-2 [Eye Diseases (rxharun.com)]
  19. Eye-Disease-Enc-eye-clopedia. [Eye Diseases (rxharun.com)]
  20. MCH-Conf-Mar-2019-6-Sandra-Staffieri-Clinical-Update-Paediatric-Eye-Disease [Eye Diseases (rxharun.com)]
  21. Adult-Hospital-Chapter-18-Eye-Disorders-with-supporting-NEMLC-report-and-reviews-2020-4-Version-1.0-30-September-2024 [Eye Diseases (rxharun.com)]
  22. hod0615i [Eye Diseases (rxharun.com)]
  23. The Cornea and Corneal Disease [Eye Diseases (rxharun.com)]
  24. August 2018 Feature [Eye Diseases (rxharun.com)]
  25. bpj54-pages8-21 [Eye Diseases (rxharun.com)]
  26. KaplanArianeDecember5CommonEye [Eye Diseases (rxharun.com)]
  27. ophthalmology-iv-handout-2016-17 [Eye Diseases (rxharun.com)]
  28. Common-Eye-Diseases-Ceu [Eye Diseases (rxharun.com)]
  29. externalEYE-DISEASE [Eye Diseases (rxharun.com)]
  30. EJHM_Volume 77_Issue 1_Pages 4754-4759 [Eye Diseases (rxharun.com)]
  31. Systemic [Eye Diseases (rxharun.com)]
  32. 9789241516570-eng [Eye Diseases (rxharun.com)]
  33. gp-handbook-common-eye-condition-management [Eye Diseases (rxharun.com)]
  34. Eye Care for FLW- Common Eye related conditions and Service Delivery Framework [Eye Diseases (rxharun.com)]
  35. hod0618i [Eye Diseases (rxharun.com)]
  36. Eye-Disorders-Guideline [Eye Diseases (rxharun.com)]
  37. kevt103 [Eye Diseases (rxharun.com)]
  38. Common Eye Diseases and their Management [Eye Diseases (rxharun.com)]
  39. eyediseases-book-aecp_Eng [Eye Diseases (rxharun.com)]

References

  1. https://www.aao.org/eye-health/
  2. https://www.nei.nih.gov/
  3. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  4. https://www.cdc.gov/vision-health/about-eye-disorders/index.html
  5. https://www.oxfordfamilyvisioncare.com/blog/different-types-of-eye-diseases/
  6. https://www.aoa.org/healthy-eyes/eye-and-vision-conditions
  7. https://www.fda.gov/media/124641/download
  8. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
  9. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  10. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  11. https://pubmed.ncbi.nlm.nih.gov/34201117/
  12. https://www.amazon.com/Eye-Book-Complete-Disorders-Hopkins/dp/1421440008
  13. https://www.amazon.com/Eye-Diseases-Disorders-Complete-Guide/dp/1922227323
  14. https://link.springer.com/book/10.1007/978-1-4471-3521-0
  15. https://www.ncbi.nlm.nih.gov/books/NBK582134/
  16. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  17. https://www.ncbi.nlm.nih.gov/mesh?
  18. https://academic.oup.com/ije/article/29/5/951/821890
  19. https://en.wikipedia.org/wiki/Category:Eye_diseases
  20. https://en.wikipedia.org/wiki/Eye_disease
  21. https://medlineplus.gov/eyediseases.html
  22. https://eye.hms.harvard.edu/ormi
  23. https://www.cera.org.au/conditions/
  24. https://jamanetwork.com/journals/jama/fullarticle/2760387
  25. https://www.sciencedirect.com/topics/nursing-and-health-professions/eye-disease
  26. https://biotechhealthcare.com/common-eye-disorders-and-diseases/
  27. https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&contentid=p00499
  28. https://pubmed.ncbi.nlm.nih.gov/35715505/
  29. https://www.sciencedirect.com/science/article/pii/S1934590918302315
  30. https://europe.ophthalmologytimes.com/view/bringing-biologics-to-eye-health-regenerative-medicine-for-inflammatory-disorders
  31. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  32. https://www.nibib.nih.gov/
  33. https://www.nei.nih.gov/
  34. https://oxfordtreatment.com/
  35. https://www.nidcd.nih.gov/health/
  36. https://consumer.ftc.gov/articles/
  37. https://www.nccih.nih.gov/health
  38. https://catalog.ninds.nih.gov/
  39. https://www.aarda.org/diseaselist/
  40. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  41. https://www.nibib.nih.gov/
  42. https://www.nia.nih.gov/health/topics
  43. https://www.nichd.nih.gov/
  44. https://www.nimh.nih.gov/health/topics
  45. https://www.nichd.nih.gov/
  46. https://www.niehs.nih.gov/
  47. https://www.nimhd.nih.gov/
  48. https://www.nhlbi.nih.gov/health-topics
  49. https://obssr.od.nih.gov/.
  50. https://www.nichd.nih.gov/health/topics
  51. https://rarediseases.info.nih.gov/diseases
  52. https://beta.rarediseases.info.nih.gov/diseases
  53. https://orwh.od.nih.gov/

 

Patient safety assistant

Check your symptom safely

Hi, I am RX Symptom Navigator. I can help you understand what to read next and what warning signs need care.
Warning: Do not use this in emergencies, pregnancy, severe illness, or as a substitute for a doctor. For children or teens, use with a parent/guardian and clinician.
A rural-friendly guide: warning signs, when to see a doctor, related articles, tests to discuss, and OTC safety education.
1 Symptom 2 Severity 3 Safe guidance
First safety question

Is there chest pain, breathing trouble, fainting, confusion, severe bleeding, stroke-like weakness, severe injury, or pregnancy danger sign?

Choose quickly

Browse by body area
Start here: Write or select a symptom. The guide will show warning signs, doctor guidance, diagnostic tests to discuss, OTC safety education, and related RX articles.

Important: This tool is educational only. It cannot diagnose, treat, or replace a doctor. OTC information is not a prescription. In an emergency, contact local emergency services or go to the nearest hospital.

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Back pain care roadmap

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • New leg weakness, numbness around private area, or loss of bladder/bowel control
  • Back pain after major injury, fever, unexplained weight loss, cancer history, or severe night pain
Doctor / service to discuss: Orthopedic/spine specialist, physical medicine doctor, physiotherapist under guidance, or qualified clinician.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Discuss neurological examination first. X-ray or MRI may be needed only when red flags, injury, nerve weakness, or persistent severe symptoms are present.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.
  • Avoid forceful massage or bone-setting when there is weakness, injury, fever, or nerve symptoms.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Congenital Iris Ectropion

    Congenital? iris ectropion is more commonly called congenital? ectropion uveae. It is a rare developmental eye condition present from birth in which the dark pigment layer...

    April 2, 2026 • Rx Eye & Vision Care (A - Z)
  2. Congenital Cystic Eyeball

    Congenital? cystic eyeball, also called congenital? cystic eye, is a very rare birth defect in which a cyst forms in the eye socket and the normal...

    March 31, 2026 • Rx Eye & Vision Care (A - Z)
  3. Congenital Anophthalmos with Cyst

    Congenital? anophthalmos with cyst is a very rare birth defect of eye development. In this condition, a child is born without a normally formed eye in...

    March 31, 2026 • Rx Eye & Vision Care (A - Z)
  4. Congenital Cystic Eye

    Congenital? cystic eye is a very rare birth condition. In this condition, a cyst-like sac grows in the eye socket where the eye should normally form....

    March 31, 2026 • Rx Eye & Vision Care (A - Z)
  5. Cerulean Cataract

    Cerulean cataract is a rare kind of childhood or developmental cataract. A cataract means the natural lens of the eye becomes cloudy instead of staying clear....

    March 12, 2026 • Rx Eye & Vision Care (A - Z)
  6. Congenital Blue Dot Cataract

    Congenital? blue dot cataract, also called cerulean cataract, is a type of childhood lens opacity in which many tiny bluish or whitish dots appear in the...

    March 12, 2026 • Rx Eye & Vision Care (A - Z)
  7. Congenital Achiasma

    Congenital? achiasma is a very rare eye and brain problem that is present from birth. It happens when the optic chiasm, the “cross-road” where nerve fibers...

    March 5, 2026 • Rx Eye & Vision Care (A - Z)
  8. Congenital Absence of Lacrimal Puncta and Salivary Glands

    Congenital? absence of lacrimal puncta and salivary glands means that a baby is born without the tiny tear drainage openings on the eyelids (lacrimal puncta) and...

    March 5, 2026 • Rx Eye & Vision Care (A - Z)
  9. Aplasia of the Lacrimal and Salivary Glands

    Aplasia of the lacrimal and salivary glands means that the tear glands and saliva glands did not grow properly before birth. They are partly formed, very...

    March 5, 2026 • Rx Eye & Vision Care (A - Z)
  10. Cone-Rod Dystrophy Type 6

    Cone-rod dystrophy type 6 (often written as CORD6) is a rare eye disease that slowly damages the light-sensing cells (cones and rods) in the retina, the...

    March 4, 2026 • Rx Eye & Vision Care (A - Z)